Results 211 to 220 of about 208,633 (265)

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer.

JAMA Netw Open
Lu CA, Jiang C, Wang AZ, Zhang T.
europepmc   +1 more source

Single-cell transcriptomic insights into the immune heterogeneity of immune checkpoint inhibitors related organ toxicities. [PDF]

Front Immunol
Wen H, Qi Y, Song J, Yan X.
europepmc   +1 more source

MIS12 Is Required for Kinetochore‐Microtubule Attachment in Oocyte Meiosis

Advanced Science, EarlyView.
A model depicting the role of MIS12 in K‐MT attachment during oocyte meiosis. The presence of MIS12 stabilizes bipolar K‐MT attachments by maintaining the function of NDC80 and its interaction with TUBB. This, in turn, promotes KNL1 assembly and subsequent SAC protein recruitment to kinetochores.
Jian Li, Chun‐Hui Zhang, Yong Wang, Cheng‐Yuan Li, Da‐Rong Wen, Xi Xia, Liang Zhou, Wei‐Ping Qian, Qing‐Yuan Sun, Chang‐Zhong Li   +9 more
wiley   +1 more source

Immune Checkpoint Inhibitors and Immunomodulators for Cancer Immunotherapy: Insights Into Resistance and Therapeutic Strategies. [PDF]

Adv Sci (Weinh)
Chen F, Yu Y, Cai X, Lin J, Liang R, Kang R, Tang D, Liu J.   +7 more
europepmc   +1 more source

Stiffness‐Activated Stellate Cells Drive Pancreatic Cancer Liver Colonization via GMFG‐TNS4 Signaling

Advanced Science, EarlyView.
Fibrotic liver stiffness activates hepatic stellate cells through Piezo1‐dependent calcium influx and ER stress, promoting EV‐associated GMFG release. Delivered GMFG engages TNS4 in pancreatic cancer cells, triggering FAK/AKT signaling, adhesion, and fatty acid synthesis.
Biwen Zhu, Jian Wan, Xue Zhang, Jiashuai Yan, Xi Chen, Xiaoqi Guan, Qianqian Ren, Tao Yang, Di Wu, Qingsong Guo, Yibing Guo, Yuhua Lu   +11 more
wiley   +1 more source

Breaking Barriers: Immune Checkpoint Inhibitors in Breast Cancer. [PDF]

Pharmaceutics
Dmuchowski B, Hryniewicz WW, Barczak I, Fręśko K, Szarzyńska Z, Węclewski H, Ślężak JK, Dobosz P, Gryczka H.   +8 more
europepmc   +1 more source

Histologic Features of Melanocytic Nevi Secondary to Melanoma Treatment With Immune Checkpoint Inhibitors. [PDF]

Cureus
Sohail N, Sohail A, Durrani S, Bilbaoa J, Abbud CA, Simpson B, Reyes Barron C.   +6 more
europepmc   +1 more source

Immune checkpoint inhibitors and myocarditis-myositis-myasthenia gravis overlap: a FAERS pharmacovigilance study with time-to-onset characterization. [PDF]

Front Pharmacol
Pacaci B, Yildirim B, Tunc MA, Demirel A, Akagunduz F, Kocaaslan E, Guren AK, Demircan NC, Bayoglu IV.   +8 more
europepmc   +1 more source

Correction: Meta-analysis of tuberculosis incidence and risk in cancer patients treated with immune checkpoint inhibitors. [PDF]

Front Oncol
Ming H, Fu B, Chen X, Hu W, Yu H.
europepmc   +1 more source

A real-world retrospective study of vitiligo associated with immune checkpoint inhibitors based on FAERS and TCGA databases. [PDF]

Medicine (Baltimore)
Ma J, Cai Z, Luo Y, Li X, Li J, Hou M, Zhu D.   +6 more
europepmc   +1 more source